Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.70 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.70 |
| ▸ | GLO1 | Q04760 | 4/20 | 0.61 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.40 |
| ▸ | GRM6 | O15303 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30382008 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL30443198 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL13930989 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL25770244 | 0.97 | PTGS1 (0.70) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL138746 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL16377441 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL19579378 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL13561367 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL18744121 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL4362052 | 0.97 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194027-B1 | COMPOSITIONS FOR USE IN TREATING PSYCHOTIC DISORDERS | SOUND PHARMACEUTICALS INCORPORATED (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12427138-B2 | Treatment of Meniere's disease | SOUND PHARMACEUTICALS INCORPORATED (US) | 2025-09-30 | — | — | US | disclosed |
| CN-119827684-A | Beijing white pear origin identification method based on metabonomics technology | 北京市农林科学院 | 2025-04-15 | — | — | CN | disclosed |
| EP-4461360-A2 | TREATMENT OF MENIERE'S DISEASE | Sound Pharmaceuticals Incorporated (US) | 2024-11-13 | — | — | EP | disclosed |
| CN-117969859-B | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-09-06 | — | — | CN | disclosed |
| EP-3458045-B1 | EBSELEN FOR USE IN THE TREATMENT OF MENIERE'S DISEASE | SOUND PHARMACEUTICALS INCORPORATED (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240050409-A1 | Methods and Compositions for Treating Psychotic Disorders | SOUND PHARMACEUTICALS INCORPORATED | 2024-02-15 | — | — | US | disclosed |
| US-20240041851-A1 | METHOD OF TREATING AND PREVENTING VIRAL INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-02-08 | — | — | US | disclosed |
| US-20230384327-A1 | GUT MICROBIOTA-RELATED METHODS FOR TREATING DEMENTIA AND AGE-DEPENDENT COGNITIVE DECLINE | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230384327-A1 | GUT MICROBIOTA-RELATED METHODS FOR TREATING DEMENTIA AND AGE-DEPENDENT COGNITIVE DECLINE | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2023-11-30 | — | — | US | disclosed |
| WO-2023116664-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | 沈阳兴齐眼药股份有限公司 | 2023-06-29 | — | — | WO | disclosed |
| US-20210379017-A1 | Methods and Compositions for Treating Psychotic Disorders | SOUND PHARMACEUTICALS INCORPORATED | 2021-12-09 | — | — | US | disclosed |
| WO-2017201318-A1 | TREATMENT OF MENIERE'S DISEASE | SOUND PHARMACEUTICALS INCORPORATED (US) | 2017-11-23 | — | — | WO | disclosed |
| US-20170246148-A1 | Methods and Compositions for Treating Psychotic Disorders | SOUND PHARMACEUTICALS INCORPORATED | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210379017-A1 | Methods and Compositions for Treating Psychotic Disorders | GPX4, GPX1, GSR | PTGS1 242/4885GSTK1 15/4885GLO1 184/4885 |
| US-12427138-B2 | Treatment of Meniere's disease | GPX1, GSR, GPX4 | PTGS1 77/4885GSTK1 58/4885GLO1 390/4885 |
| US-20240041851-A1 | METHOD OF TREATING AND PREVENTING VIRAL INFECTION | DHFR, FAH, HAVCR2 | PTGS1 771/4885GSTK1 201/4885GLO1 90/4885 |
| US-20240050409-A1 | Methods and Compositions for Treating Psychotic Disorders | GPX4, GPX1, GSR | PTGS1 242/4885GSTK1 15/4885GLO1 184/4885 |
| US-20170246148-A1 | Methods and Compositions for Treating Psychotic Disorders | GPX4, GPX1, GSR | PTGS1 235/4885GSTK1 14/4885GLO1 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.